^ ab“Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size”. Genes Cells11 (7): 757–66. (July 2006). doi:10.1111/j.1365-2443.2006.00977.x.
PMID16824195.
^“Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR”. FEBS Lett.453 (3): 387–90. (June 1999). doi:10.1016/s0014-5793(99)00762-0.
PMID10405182.
^“Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors”. Eur. J. Biochem.269 (12): 3076–85. (June 2002). doi:10.1046/j.1432-1033.2002.02992.x.
PMID12071973.
^“Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase”. J. Biol. Chem.275 (15): 10779–87. (April 2000). doi:10.1074/jbc.275.15.10779.
PMID10753870.
^“Structural and thermodynamic behavior of eukaryotic initiation factor 4E in supramolecular formation with 4E-binding protein 1 and mRNA cap analogue, studied by spectroscopic methods”. Chem. Pharm. Bull.49 (10): 1299–303. (October 2001). doi:10.1248/cpb.49.1299.
PMID11605658.
^ ab“Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1”. J. Biol. Chem.281 (34): 24293–303. (August 2006). doi:10.1074/jbc.M603566200.
PMID16798736.
^“PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals”. Cell. Signal.18 (12): 2283–91. (December 2006). doi:10.1016/j.cellsig.2006.05.021.
PMID16837165.
^“Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1”. J. Biol. Chem.278 (42): 40717–22. (October 2003). doi:10.1074/jbc.M308573200.
PMID12912989.
^“The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif”. J. Biol. Chem.278 (18): 15461–4. (May 2003). doi:10.1074/jbc.C200665200.
PMID12604610.
^“mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery”. Cell110 (2): 163–75. (July 2002). doi:10.1016/s0092-8674(02)00808-5.
PMID12150925.
^“Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro”. Genes Cells5 (9): 765–75. (September 2000). doi:10.1046/j.1365-2443.2000.00365.x.
PMID10971657.
“4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications”. Cancer Res.67 (16): 7551–7555. (2007). doi:10.1158/0008-5472.CAN-07-0881.
PMID17699757.
“Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in rat adipocytes”. J. Biol. Chem.269 (37): 23185–91. (1994). doi:10.1016/S0021-9258(17)31637-X.
PMID8083223.
“The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth”. Oncogene13 (11): 2415–20. (1997).
PMID8957083.
“Tissue distribution, genomic structure, and chromosome mapping of mouse and human eukaryotic initiation factor 4E-binding proteins 1 and 2”. Genomics38 (3): 353–363. (1997). doi:10.1006/geno.1996.0638.
PMID8975712.
“Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes”. J. Biol. Chem.272 (15): 10240–10247. (1997). doi:10.1074/jbc.272.15.10240.
PMID9092573.
“The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus”. J. Biol. Chem.272 (51): 32547–32550. (1998). doi:10.1074/jbc.272.51.32547.
PMID9405468.
“Phosphorylation of human MAD1 by the BUB1 kinase in vitro”. Biochem. Biophys. Res. Commun.257 (2): 589–595. (1999). doi:10.1006/bbrc.1999.0514.
PMID10198256.
“Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTOR”. FEBS Lett.453 (3): 387–390. (1999). doi:10.1016/S0014-5793(99)00762-0.
PMID10405182.
“Substrate specificities and identification of putative substrates of ATM kinase family members”. J. Biol. Chem.274 (53): 37538–37543. (2000). doi:10.1074/jbc.274.53.37538.
PMID10608806.
“Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies”. J. Biol. Chem.275 (43): 33836–33843. (2000). doi:10.1074/jbc.M006005200.
PMID10942774.